1,053 results on '"Bristol-Myers Squibb Co. -- Forecasts and trends"'
Search Results
202. Advanced Cervical Cancer Pipeline 2023 | Key Companies - AstraZeneca, GlaxoSmithKline, Advaxis, Bristol-Myers Squibb, Innovent Biologics, Shanghai Henlius Biotech, Genexine, Inc., Merck, and Others
203. Acute Myeloid Leukemia Pipeline Insight | Key Companies - Takeda, Bristol-Myers Squibb, Allogene Therapeutics, Novartis, Janssen, Teva Pharma, Bristol-Myers Squibb, and Others
204. Advanced Gastric Carcinoma Pipeline 2023 | Key Companies - BeiGene, Bristol-Myers Squibb, Hanmi Pharmaceutical, AstraZeneca, Genentech, Seagen Inc, Bicycle Tx Limited, Vedanta Biosciences Inc, and othe
205. Psoriatic Arthritis Market to Register Immense Growth During the Forecast Period (2022-2032) - DelveInsight | Key Companies - AbbVie, UCB Biopharma, BMS, Affibody AB, AltruBio, Sun Pharma, Janssen
206. Autoimmune Drugs Market size to grow by USD 29,314.5 million between 2022 and 2027; AbbVie Inc., and AdvaCare Pharma among others, identified as key vendors - Technavio
207. Eosinophilic Esophagitis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Key Companies - Regeneron, Sanofi, Bristol-Myers, Astrazeneca
208. Global Small Molecule API Market Report 2023: Growing Demand for Small Molecule Drugs Fuels the Sector
209. PD1 and PDL1 Inhibitors Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Incyte Corporation, Bristol-Myers Squibb, Novartis, Bayer, Beigene, Merck, AbbVie, and Others Expected to Propel Market
210. PD1 and PDL1 Inhibitors Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Incyte Corporation, Bristol-Myers Squibb, Novartis, Bayer, Beigene, Merck, AbbVie, and Others Expected to Propel Market
211. Merkel Cell Carcinoma Market Size & Share, Epidemiology & Competitive Analysis Report 2032 | Companies - Bristol-Myers Squibb, Incyte corporation, Kartos Therapeutics, NantKwest
212. Multiple Myeloma Market Analysis, Market Size, Epidemiology, Leading Companies | Companies - BMS, AstraZeneca, Pfizer, Array Biopharma, BioLineRx, MorphoSys AG, I-Mab Biopharma, Chipscreen Biosciences
213. Examining the Latest Breakthroughs in the Advanced Merkel Cell Carcinoma Pipeline| Key Companies - Exelixis, Bristol-Myers Squibb, and Others
214. Self-Injections Global Market Report 2023
215. Multiple Myeloma Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest FDA, EMA, PDMA Approvals by DelveInsight | Key Companies - Roche, AbbVie, Janssen Pharmaceutical, Regeneron Pharma
216. Global Analgesics Market Report 2023: Sector is Expected to Reach $67.4 Billion by 2028 at a CAGR of 4.49% - ResearchAndMarkets.com
217. Global Analgesics Market Report 2023: Sector is Expected to Reach $67.4 Billion by 2028 at a CAGR of 4.49%
218. DelveInsight Evaluates a Robust Waldenstrom's Macroglobulinemia Pipeline as 20+ Influential Pharma Players to Set Foot in the Domain
219. Advanced Gastric Carcinoma Pipeline Assets and Comparative Analysis of Clinical and Non-Clinical Stage Products | Major Companies - Bristol-Myers Squibb, AstraZeneca, Genentech, and Others
220. Next-Generation Immunotherapies Market Evolving at a Rapid Pace, Predicts DelveInsight | Key Companies Active in the Domain - Regeneron, Boehringer Ingelheim, Sanofi, AstraZeneca, Roche, Merck, Incyte, GSK, Novartis
221. Next-Generation Immunotherapies Market Evolving at a Rapid Pace, Predicts DelveInsight | Key Companies Active in the Domain - Regeneron, Boehringer Ingelheim, Sanofi, AstraZeneca, Roche, Merck, Incyte, GSK, Novartis
222. DelveInsight Highlights Major Metastatic Melanoma Pipeline Therapies and 75+ Leading Players Wheeling the Hypertension Pipeline Landscape
223. 75+ Leading Players Wheeling the Major Depressive Disorder Pipeline Landscape 2023 | Companies - Bristol-Myers Squibb, Janssen and Others
224. Propulsion of Multiple Sclerosis Pipeline as Novel and Extensive 100+ Therapies Likely to Enter in the Treatment Domain | Major Companies - Biogen, Takeda, Gilead Sciences, and Others
225. Global Psoriatic Arthritis Treatment Market Report 2023: Recent Development of Interleukin-17 Inhibitors Drives Growth - ResearchAndMarkets.com
226. Global Psoriatic Arthritis Treatment Market Report 2023: Recent Development of Interleukin-17 Inhibitors Drives Growth
227. 135+ Active Companies working to develop 150+ Pipeline Therapies for Non-Small Cell Lung Cancer Treatment Landscape | Major Companies - AbbVie, Pfizer, Bayer, Imugene, and Others
228. DelveInsight Highlights Major Advances, Transformative Therapies, and 80+ Leading Players Wheeling the Crohn's Disease Pipeline Landscape
229. Anaplastic Thyroid Cancer Drugs Market size to grow at a CAGR of 5.44% from 2021 to 2026, Driven by the high prevalence of thyroid cancer - Technavio
230. Ewing's Sarcoma Treatment Market size to grow by USD 302.5 million from 2021 to 2026, Driven by the growing awareness about and funding for Ewing's sarcoma - Technavio
231. Cell therapy market size to grow by USD 21.061 billion from 2021 to 2026; Astellas Pharma Inc., Athersys Inc., among others, emerge as key vendors - Technavio
232. BRAF Mutant Metastatic Melanoma Market Evolving at a Rapid Pace, Estimates DelveInsight | Key Companies Active in the Domain - Merck Sharp & Dohme, Eisai, Iovance Biotherapeutics, Genentech, Amgen, AstraZeneca, Pfizer, and Others
233. Thyroid Cancer Market to Grow at a Substantial Growth Rate, Predicts DelveInsight | Novartis, AffyImmune Therapeutics, Eli Lilly, Loxo Oncology, Bristol-Myers Squibb, and Others Expected to Propel Market
234. Antimicrobial Therapeutics Market size to grow by USD 51.4 billion from 2022 to 2027, Driven by initiatives from government agencies in the pharmaceutical industry - Technavio
235. Deep Vein Thrombosis Market to Observe Impressive Growth During the Forecast Period (2022-2032), Evaluates DelveInsight | Key Companies - Bayer, Abbott Labs, Bristol-Myers Squibb, Pfizer, Sanofi
236. Systemic Lupus Erythematous Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examine DelveInsight | Key Companies - AstraZeneca, Eli Lilly and Company, UCB Pharma
237. Non-small Cell Lung Cancer Drugs Market size to grow by USD 30.23 billion from 2021 to 2026, Driven by the increasing prevalence and incidence of non-small cell lung cancer - Technavio
238. Germany Cell and Gene Therapy Market Report 2023: Players Include Novartis, Gilead Sciences, Spark Therapeutics, Amgen and Orchard Therapeutics
239. Non-small Cell Lung Cancer Drugs Market size to grow by USD 30.23 billion from 2021 to 2026, Driven by the increasing prevalence and incidence of non-small cell lung cancer - Technavio
240. Rich Insights into the Heart Failure Clinical Trial Analysis Featuring 75+ Companies and Therapies | DelveInsight
241. Germany Cell and Gene Therapy Market Report 2023: Players Include Novartis, Gilead Sciences, Spark Therapeutics, Amgen and Orchard Therapeutics - ResearchAndMarkets.com
242. Germany Cell and Gene Therapy Market Report 2023: Players Include Novartis, Gilead Sciences, Spark Therapeutics, Amgen and Orchard Therapeutics
243. Germany Cell and Gene Therapy Market - Focused Insights 2023-2028: Sector to Reach $3.44 Billion by 2028 at a 40% CAGR
244. Europe Cell and Gene Therapy Market Report 2023: Drug Developers Prioritize CAR-T Cell-Based Therapies with Over 1000 Trials Ongoing
245. Europe Cell and Gene Therapy Market Report 2023: Sector to Reach $15.15 Billion by 2028 at a 38.2% CAGR
246. Germany Cell and Gene Therapy Market - Focused Insights 2023-2028: Sector to Reach $3.44 Billion by 2028 at a 40% CAGR
247. Europe Cell and Gene Therapy Market Report 2023: Government, as Well as Industrial and Academic Financing and Collaboration Among Small and Large Biopharmaceutical Companies Bolsters Sector
248. Europe Cell and Gene Therapy Market Report 2023: Sector to Reach $15.15 Billion by 2028 at a 38.2% CAGR - ResearchAndMarkets.com
249. Europe Cell and Gene Therapy Market Report 2023: Sector to Reach $15.15 Billion by 2028 at a 38.2% CAGR
250. Non-hodgkin lymphoma therapeutics market size to increase by USD 5,427.51 million between 2022 and 2027; Growing awareness about cancer as a key trend - Technavio
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.